SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-340964
Filing Date
2012-08-07
Accepted
2012-08-07 16:20:52
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d352639d10q.htm 10-Q 739283
2 EX-31.1 d352639dex311.htm EX-31.1 6557
3 EX-31.2 d352639dex312.htm EX-31.2 6553
4 EX-32.1 d352639dex321.htm EX-32.1 3606
5 EX-32.2 d352639dex322.htm EX-32.2 3414
  Complete submission text file 0001193125-12-340964.txt   4751461

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tsrx-20120630.xml EX-101.INS 686635
7 XBRL TAXONOMY EXTENSION SCHEMA tsrx-20120630.xsd EX-101.SCH 44402
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tsrx-20120630_cal.xml EX-101.CAL 45064
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tsrx-20120630_def.xml EX-101.DEF 121370
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsrx-20120630_lab.xml EX-101.LAB 327392
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsrx-20120630_pre.xml EX-101.PRE 242353
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34828 | Film No.: 121013487
SIC: 2834 Pharmaceutical Preparations